BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32690497)

  • 61. Protocol for developing a core outcome set for evaluating school-based physical activity interventions in primary schools.
    Foley KA; Venkatraman T; Ram B; Ells L; van Sluijs E; Hargreaves DS; Greaves F; Taghavi Azar Sharabiani M; Viner RM; Bottle A; Saxena S
    BMJ Open; 2019 Dec; 9(12):e031868. PubMed ID: 31852702
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Velamentous cord insertion associated with vasa praevia].
    Schoenen S; Emonts P; Van Linthout C
    Rev Med Liege; 2020 Jan; 75(1):6-9. PubMed ID: 31920037
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of a core outcome set for informed consent for therapy: An international key stakeholder consensus study.
    Convie LJ; Clements JM; McCain S; Campbell J; Kirk SJ; Clarke M
    BMC Med Ethics; 2022 Aug; 23(1):79. PubMed ID: 35945581
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acute severe paediatric asthma: study protocol for the development of a core outcome set, a Pediatric Emergency Reserarch Networks (PERN) study.
    Craig S; Babl FE; Dalziel SR; Gray C; Powell C; Al Ansari K; Lyttle MD; Roland D; Benito J; Velasco R; Hoeffe J; Moldovan D; Thompson G; Schuh S; Zorc JJ; Kwok M; Mahajan P; Johnson MD; Sapien R; Khanna K; Rino P; Prego J; Yock A; Fernandes RM; Santhanam I; Cheema B; Ong G; Chong SL; Graudins A;
    Trials; 2020 Jan; 21(1):72. PubMed ID: 31931862
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Vasa previa: Of the diagnosis to neonatal prognosis].
    Aissi G; Sananes N; Veujoz M; Felder A; Kasbaoui SM; Trieu NT; Favre R; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 2013 Oct; 42(6):591-5. PubMed ID: 23287072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of a core outcome set for effectiveness studies of breech birth at term (Breech-COS)-an international multi-stakeholder Delphi study: study protocol.
    Walker S; Dasgupta T; Shennan A; Sandall J; Bunce C; Roberts P
    Trials; 2022 Apr; 23(1):249. PubMed ID: 35379305
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protocol for the development of a core outcome set for studies of pregnant women with pre-existing multimorbidity.
    Lee SI; Eastwood KA; Moss N; Azcoaga-Lorenzo A; Subramanian A; Anand A; Taylor B; Nelson-Piercy C; Yau C; McCowan C; O'Reilly D; Hope H; Kennedy JI; Abel KM; Locock L; Brocklehurst P; Plachcinski R; Brophy S; Agrawal U; Thangaratinam S; Nirantharakumar K; Black M
    BMJ Open; 2021 Oct; 11(10):e044919. PubMed ID: 34716152
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Velamentous insertion of the umbilical cord vessels with vasa praevia--a case report.
    Siminel MA; Gheonea C; Stănescu MR; Comănescu AC; Dijmărescu AL; NeamŢu SD; Cotoi BV; NedelcuŢă RM; Niculescu EC
    Rom J Morphol Embryol; 2015; 56(1):301-8. PubMed ID: 25826521
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Third-trimester fetoscopic ablation therapy for types II and III vasa previa.
    Chmait RH; Monson MA; Chon AH; Masri J; Korst LM; Incerpi MH
    Am J Obstet Gynecol; 2024 Jan; 230(1):87.e1-87.e9. PubMed ID: 37741533
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vasa previa rupture in velamentous insertion of the umbilical cord: an analysis and report of a case.
    Zhang Z
    Clin Exp Obstet Gynecol; 2016; 43(4):606-608. PubMed ID: 29734559
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Agreement on what to measure in randomised controlled trials in burn care: study protocol for the development of a core outcome set.
    Young A; Brookes S; Rumsey N; Blazeby J
    BMJ Open; 2017 Jul; 7(6):e017267. PubMed ID: 28669969
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of a core outcome set for studies involving patients undergoing major lower limb amputation for peripheral arterial disease: study protocol for a systematic review and identification of a core outcome set using a Delphi survey.
    Ambler GK; Bosanquet DC; Brookes-Howell L; Thomas-Jones E; Waldron CA; Edwards AGK; Twine CP
    Trials; 2017 Dec; 18(1):628. PubMed ID: 29284523
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol.
    Nielsen KK; O'Reilly S; Wu N; Dasgupta K; Maindal HT
    Trials; 2018 Dec; 19(1):708. PubMed ID: 30594221
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Core Outcome DEvelopment for Carrier Screening (CODECS) study: protocol for development of a core outcome set.
    Richardson E; McEwen A; Newton-John T; Manera K; Jacobs C
    Trials; 2021 Jul; 22(1):480. PubMed ID: 34294124
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of a core outcome set for multimorbidity trials in low/middle-income countries (COSMOS): study protocol.
    Boehnke JR; Rana RZ; Kirkham JJ; Rose L; Agarwal G; Barbui C; Chase-Vilchez A; Churchill R; Flores-Flores O; Hurst JR; Levitt N; van Olmen J; Purgato M; Siddiqi K; Uphoff E; Vedanthan R; Wright J; Wright K; Zavala GA; Siddiqi N
    BMJ Open; 2022 Feb; 12(2):e051810. PubMed ID: 35172996
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis.
    Takemoto Y; Matsuzaki S; Matsuzaki S; Kakuda M; Lee M; Hayashida H; Maeda M; Kamiura S
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672661
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is scanning for vasa previa important for singleton pregnancies that started as multiple conceptions?
    Melcer Y; Pekar-Zlotin M; Wolf B; Betser M; Dvash S; Zilberman Sharon N; Maymon R
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():100-103. PubMed ID: 31128531
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Core outcome set for studies investigating management of selective fetal growth restriction in twins.
    Townsend R; Duffy JMN; Sileo F; Perry H; Ganzevoort W; Reed K; Baschat AA; Deprest J; Gratacos E; Hecher K; Lewi L; Lopriore E; Oepkes D; Papageorghiou A; Gordijn SJ; Khalil A;
    Ultrasound Obstet Gynecol; 2020 May; 55(5):652-660. PubMed ID: 31273879
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey.
    MacLennan S; Bekema HJ; Williamson PR; Campbell MK; Stewart F; MacLennan SJ; N'Dow JM; Lam TB
    Trials; 2015 Mar; 16():76. PubMed ID: 25887437
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The outcomes of Perthes' disease of the hip: a study protocol for the development of a core outcome set.
    Leo DG; Leong WY; Gambling T; Long A; Murphy R; Jones H; Perry DC
    Trials; 2018 Jul; 19(1):374. PubMed ID: 30005667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.